摘要 |
The invention relates to an in vitro method for predicting metastasis in a subject diagnosed with breast cancer and treated with a taxane, with an in vitro method for the selection of patients with breast cancer that are at risk of developing metastasis following treatment with taxane, and an in vitro method for the design of a personalised therapy for a subject suffering from breast cancer and who is being treated with taxane, based on determining the level of GRP94 and/or FN14. The invention also relates to a composition comprising a taxane and a GRP94 inhibitor and/or an FN14 inhibitor, and to the use thereof in the treatment of cerebral metastasis. |